Home | Welcome to Contract Pharma   
Last Updated Monday, May 25 2015


Covance Acquires Medaxial

Published May 20, 2014
Related Searches: Biopharma contractpharma.com Development Pharma
Covance has acquired Medaxial, a communication consultancy that specializes in offering an integrated approach to market access strategy, health economic modeling, and data dissemination services to the pharma, biopharma and medical device industries.
Based in London, with offices in NY, Antwerp, and Belgium, Medaxial expands Covance’s market access services currently located in Gaithersburg, MD, Greenfield, IN, San Diego and Sydney. 
"Covance is a leader in the rapidly growing sector of market access and reimbursement.  Medaxial, with their proven expertise in optimizing data-driven, solution-focused communication of a medical product's value will further complement our market access offerings," said Marc Ginsky, vice president and general manager, Covance Market Access. "Proactive and effective communication of clinical and economic value is critical to help clients navigate an increasingly complex drug development and payment landscape, as they strive to provide innovative medical products to patients."
"Our capabilities and our commitment to client service are in line with Covance's commitment to operational and service excellence," said Paul Mcloughlin, co-founder and Director, Technology and Design, Medaxial. "This acquisition will provide clients with the benefits of a global consultancy group with local expertise."

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On